Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
RO7300490 is bispecific compound that targets CD40 and FAP, which acts as a CD40 agonist and has potential antitumor activity (PMID: 34043482).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Atezolizumab + RO7300490||Atezolizumab RO7300490||0||1|